HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G P Summerfield Selected Research

Lymphoma (Lymphomas)

11/2006The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G P Summerfield Research Topics

Disease

1Neutropenia
12/2016
1Hyperthyroidism
12/2016
1Graves Disease (Basedow Disease)
12/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2006
1Lymphoma (Lymphomas)
11/2006
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2001
1Multiple Myeloma
10/2000

Drug/Important Bio-Agent (IBA)

2Dexamethasone (Maxidex)FDA LinkGeneric
11/2006 - 10/2000
1Thyroid HormonesIBA
12/2016
1Antithyroid Agents (Antithyroid Drugs)IBA
12/2016
1Chlorambucil (Leukeran)FDA Link
11/2006
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
11/2006
1fludarabineIBA
04/2001

Therapy/Procedure

1Therapeutics
12/2016
1Time-to-Treatment
11/2006